1558 — Yichang Hec Changjiang Pharmaceutical Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$11.44bn
- HK$12.43bn
- CNY6.29bn
- 79
- 80
- 99
- 99
Annual cashflow statement for Yichang Hec Changjiang Pharmaceutical Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | ARS | ARS | ARS | ARS | |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | 2,269 | 1,010 | -667 | 39.4 | — |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 180 | -308 | 223 | 1,143 | — |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -741 | 475 | -478 | 140 | — |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 1,794 | 1,299 | -663 | 1,700 | — |
| Capital Expenditures | -1,673 | -1,918 | -580 | -853 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -37.6 | -177 | 141 | -267 | — |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1,710 | -2,095 | -439 | -1,120 | — |
| Financing Cash Flow Items | -59.5 | -95.2 | -99.8 | -151 | — |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2,100 | 64.6 | 187 | -787 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 2,185 | -734 | -914 | -208 | — |